Drug Profile
LI 401
Alternative Names: LI-401Latest Information Update: 08 Jun 2010
Price :
$50
*
At a glance
- Originator Enhance Biotech
- Class Anti-inflammatories
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Gingivitis
Most Recent Events
- 18 May 2006 Development discontinued for Gingivitis during 2006
- 20 Sep 2004 Phase-II clinical trials in Gingivitis in USA (Topical)